Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHENERGYZE: Sonlicromanol in m.3243A>G Mitochondrial Disease
NCT04165239Phase 2Completed
- Sponsor
- Khondrion
- Start
- Oct 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of sonlicromanol in mitochondrial disease, sponsored by Khondrion. Started Oct 2019; status: completed.
02
Drugs
sonlicromanol
03
Conditions
mitochondrial disease
Beyond the preview
Go deeper on NCT04165239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04165239.